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Exosomes are a particular type of extracellular vesicle, characterized by their endosomal
origin as intraluminal vesicles present in large endosomes with a multivesicular structure.
After these endosomes fuse with the plasma membrane, exosomes are secreted into
the extracellular space. The ability of exosomes to carry and selectively deliver bioactive
molecules (e.g., lipids, proteins, and nucleic acids) confers on them the capacity to
modulate the activity of receptor cells, even if these cells are located in distant tissues or
organs. Since exosomal cargo depends on cell type, a detailed understanding of the
mechanisms that regulate the biochemical composition of exosomes is fundamental
to a comprehensive view of exosome function. Here, we review the latest advances
concerning exosome function and biogenesis in T cells, with particular focus on the
mechanism of protein sorting at multivesicular endosomes. Exosomes secreted by
specific T-cell subsets can modulate the activity of immune cells, including other
T-cell subsets. Ceramide, tetraspanins and MAL have been revealed to be important
in exosome biogenesis by T cells. These molecules, therefore, constitute potential
molecular targets for artificially modulating exosome production and, hence, the immune
response for therapeutic purposes.
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INTRODUCTION
Exosomes are nano-sized membranous vesicles (40–100 nm in diameter) that are secreted into
the extracellular space by many cell types. The distinctive characteristic of these vesicles is their
endosomal origin as intraluminal vesicles (ILV) within multivesicular endosomes (MVE). This
origin contrasts with that of other extracellular vesicles of similar size such as shedding vesicles
or ectosomes, which are released from the plasma membrane (Kalra et al., 2012; Raposo and
Stoorvogel, 2013). The accumulation of “membrane-bound vesicles” in the lumen of MVE as result
of the inward invagination of its limiting membrane, as well as the release of “vesicular inclusions”
into the extracellular space after the fusion of MVE with the plasma membrane was firstly observed
by Philip Stahl’s group in 1983 during studies of the traffic of the transferrin receptor in rat
reticulocytes (Harding et al., 1983). This finding was consistent with the selective externalization
of this receptor in vesicles by maturating sheep reticulocytes observed simultaneously by Rose
Johnstone’s group (Pan and Johnstone, 1983). A few years later, the term exosomes was coined
to refer to the population of vesicles that are released into the extracellular space upon fusion
of MVE with the plasma membrane and that can be recovered from the 100,000× g pellet
of cell-free supernatants of cell culture medium or extracellular fluids (Johnstone et al., 1987).
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Exosomes have been isolated from a great variety of cultured cells
and body fluids, including ascite fluid (Andre et al., 2002; Navabi
et al., 2005), bronchoalveolar lavage fluid (Admyre et al., 2003),
urine (Pisitkun et al., 2004), blood plasma (Caby et al., 2005),
synovial fluid (Skriner et al., 2006), breast milk (Admyre et al.,
2007), amniotic fluid (Keller et al., 2007), cerebrospinal fluid
(Vella et al., 2008), saliva (Ogawa et al., 2008), semen (Poliakov
et al., 2009), bile (Masyuk et al., 2010) and nasal mucus (Wu et al.,
2015). Within the immune system, exosome secretion has been
described in both innate and adaptive immune cells, including
B cells (Raposo et al., 1996), dendritic cells (Zitvogel et al.,
1998), platelets (Heijnen et al., 1999), mast cells (Skokos et al.,
2001), T cells (Blanchard et al., 2002), macrophages (Nguyen
et al., 2003) and natural killer cells (Lugini et al., 2012). A major
breakthrough in our current understanding of exosome function
is the finding that in addition to lipids, proteins and mRNA,
exosomes contain miRNA that can be transferred to recipient
cells to modulate their activity (Valadi et al., 2007). Therefore,
although they were originally described as being a by-product
of red cells maturation, it has become evident after 30 years of
exosome research that exosomes play an active role as vehicles
for intercellular communication by transporting a wide range of
bioactive molecules between different cells and tissues (Tkach
and Théry, 2016). This role allows exosomes to regulate many
physiological activities, including the immune response.
GENERAL MECHANISMS OF EXOSOME
BIOGENESIS
Exosomes originate as ILV during the maturation of MVE
(Huotari and Helenius, 2011; Hanson and Cashikar, 2012).
Depending on the final destination of their ILV, two main
kinds of MVE are defined: degradative MVE, which fuse with
lysosomes to promote the breakdown of their intraluminal
content, and secretory MVE, which fuse with the plasma
membrane to release their cargo into the extracellular space. In
addition, MVE are implicated in the formation of specialized
endosome compartments such as melanosomes in pigment cells
andWeibel-Palade bodies in endothelial cells (Marks et al., 2013).
Independently of their final destination, ILV formation relies on
the recruitment of specific lipids and proteins on the limiting
membrane of MVE, and then on their lateral segregation in order
to promote the organization of specialized subdomains, from
where ILV inward budding occurs.
The protein content of exosome fractions obtained from the
100,000 × g pellet have been characterized in many types of cell.
Exosomes contain proteins normally associated with intracellular
trafficking such as Rab-family GTPases, annexins, SNAREs,
and the endosomal sorting complexes required for transport
(ESCRT)-associated proteins tsg101 and Alix. Since the first
description of the tetraspanins CD37, CD63, CD81, and CD82
being enriched in exosomes secreted by B-cells (Escola et al.,
Abbreviations: ESCRT, endosomal sorting complexes required for transport;
ILV, intraluminal vesicle(s); LBPA, lysobisphosphatidic acid; MVE, multivesicular
endosome(s); nSMNase II, neutral sphingomyelinase II; TEM, tetraspanin-
enriched microdomain(s).
1998), various members of this extended family of proteins have
been found as being enriched in exosomes of different cell origin
(Andreu and Yáñez-Mó, 2014). Exosomes have high contents
of cholesterol, sphingomyelin, ceramide and ganglioside GM3
(Wubbolts et al., 2003; Subra et al., 2007; Trajkovic et al., 2008;
Llorente et al., 2013; Bosque et al., 2016), which are all of them
lipids that are concentrated in condensed membrane domains
often referred to as membrane rafts (Lingwood and Simons,
2010). Consistent with this observation, exosomes are enriched in
proteins associated with these specialized membranes (Wubbolts
et al., 2003; Staubach et al., 2009; Dubois et al., 2015), including
molecules whose protein moiety is linked to the external leaflet
of the membrane by a glycosylphosphatidylinositol anchor, such
as CD59 and the enzyme acetylcholinesterase (Johnstone et al.,
1987; Rooney et al., 1993; Rabesandratana et al., 1998; De Gassart
et al., 2003) or is linked to the internal leaflet by fatty acids, such
as Src-family tyrosine kinases (De Gassart et al., 2003), or by
proteins with membrane-associated domains, such as caveolin-
1 and the membrane tetraspanning MAL protein (Llorente et al.,
2004; Ventimiglia et al., 2015).
The ESCRT machinery is involved in the formation of
ILV in MVE and the recruitment of ubiquitinated proteins
to target them for degradation in lysosomes (Babst et al.,
2002a,b; Bache et al., 2003). Tetraspanins on one hand, and
lipids and proteins associated with condensed membranes on the
other, promote segregation of specific membrane subdomains
through the organization of protein-protein and protein-lipid
interaction networks, respectively. Consistent with the presence
in exosomes of ESCRT-associated machinery, tetraspanins and
condensed membranes, it has been proposed that distinct
molecular mechanisms sort the exosome cargo and deform the
membranes required for the inward invagination of ILV destined
for secretion as exosomes (Figure 1). However, whether these
mechanisms act separately in the same cell to give rise to distinct
subpopulations of MVE with a single type of ILV each, converge
to generate distinct subsets of ILV in a single type of MVE,
or coordinate to generate a single type of ILV structured into
discrete membrane domains remains to be clarified. In this
regard, evidence exists supporting either possibility. For instance,
depending on their activation state, dendritic cells sort MHC II
molecules to degradative MVE in a ESCRT-dependent manner
or, upon the incorporation of MHC II molecules in tetraspanin-
containing condensed membranes, to secretory MVE (Buschow
et al., 2009). In addition, it was demonstrated that inactivation
of the syndecan-syntenin-Alix axis in breast epithelial MCF-7
cells reduces the release of CD63-positive exosomes, suggesting
collaboration between ESCRT and tetraspanins in the biogenesis
of secretoryMVE (Baietti et al., 2012). It is not clear why different
cell types use distinct mechanisms for exosome biogenesis. A
possibility is that, whereas most cargos can use any of the
mechanisms, certain cargoes require specific machinery to be
sorted to ILV destined for exosomes.
ESCRT-Mediated Sorting
The ESCRT machinery consists of five protein complexes known
as ESCRT-0, -I, -II, -III, and Vps4, and several accessory
proteins including Alix (Henne et al., 2011; Schuh and Audhya,
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FIGURE 1 | General mechanisms of exosome biogenesis. (A) The
intraluminal budding of specific membrane nanodomains from the limiting
membrane of MVE gives rise to ILV. The sorting of cargo and the invagination
of ILV could be mediated by the activity of the ESCRT machinery (red), TEM
(blue) or specific lipids such as cholesterol or ceramide (green). (B,C)
Secretory MVE are transported to the plasma membrane and release their ILV
into the extracellular space after membrane fusion. (D) The ESCRT-mediated
sorting of ubiquitinated proteins gives rise to degradative MVE that fused with
lysosomes for degradation of their intraluminal cargo. It is not known whether
distinct exosomes and ILV to be secreted as exosomes exist or there is only
one class with discrete subdomains. For the sake of simplicity, the three
mechanisms were represented in the same MVE, but it remains to be
determined whether each mechanism originates a specific kind of MVE or if
different populations of ILV coexist in a single MVE. In addition three types of
ILV and exosomes are represented although is not clear whether exist different
three types of structure or a single structure with discrete subdomains. The
molecules involved in the different processes are indicated.
2014). ESCRT components work sequentially in order to
sequestrate ubiquitinated proteins in phosphatidylinositol-3-
phosphate-enriched domains of the MVE limiting membrane
and then facilitate the inward invagination of these domains,
promoting the budding and pinching off of ILV. However, the
involvement of the ESCRT in the formation of ILV with a
secretory destination is less general and seems to be dependent on
the cell type and the physiological status of the cells. An shRNA-
based screen of 23 ESCRT components in epithelial HeLa cells
showed that not all the members of the complex have a role in
exosome formation (Colombo et al., 2013). Thus, silencing of the
ESCRT-0 members Hrs and Stam1 or the ESCRT-I component
tsg101 reduced the release of exosomes, whereas silencing of
Vps4 increased it. A role for the accessory protein Alix in sorting
the transferrin receptor into exosomes was also observed in
erythrocytes (Géminard et al., 2004). In a different study Alix,
tsg101, and the ESCRT-III subunits CHMP4A, B, and C were
shown to be required for exosome secretion in breast carcinoma
MCF-7 cells through a mechanism involving the interaction of
Alix with syndecans-syntenin (Baietti et al., 2012). Finally, it
was observed that the ESCRT-0 protein Hrs is required for the
release of exosomes in dendritic cells (Tamai et al., 2010). On the
other hand, a number of studies indicate that ESCRT components
are dispensable for exosome secretion, suggesting the existence
of ESCRT-independent mechanisms. For instance, the silencing
of Hrs, tsg101, and Alix, as well as the overexpression of a
dominant negative mutant of Vps4 had no effect on intraluminal
sorting or exosomal release of the proteolipid protein in mouse
oligodendroglial Oli-neu cells (Trajkovic et al., 2008). Hrs was
also shown to be dispensable for sorting of the pigment cell-
specific protein 17 into melanosomal ILV in MNT-1 melanoma
cells (Theos et al., 2006).
Tetraspanin-Mediated Sorting
The tetraspanin protein family consists of 33 members in
humans. Tetraspanins have low sequence homology but are
similarly structured in four transmembrane domains with both
amino- and carboxyl-termini of the molecule oriented toward
the cytoplasm. Tetraspanins interact with themselves and with
other membrane and cytosolic proteins to organize a particular
kind of membrane domains known as tetraspanin-enriched
microdomains (TEM). Tetraspaninsmediate a number of cellular
processes including cell adhesion, immune activation, tumor
and immune cell extravasation, virus entry and intracellular
trafficking regulation (Yáñez et al., 2009; Charrin et al., 2014).
TEM appear to play a role in sorting the intraluminal cargo
and the secretion of exosomes. In dendritic cells, the loading
of MHC-II in exosomes depends on its incorporation into
membrane domains enriched in the tetraspanin CD9 (Buschow
et al., 2009), and this protein was also shown to be required for
the incorporation of the metalloprotease CD10 into exosomes of
erythroleukemic K562 cells (Mazurov et al., 2013). Bone marrow
dendritic cells derived from CD9 knockout mice show reduced
secretion of exosomes, while the overexpression of tetraspanins
CD9 or CD82 in human embryonic kidney 293 cells increases
the incorporation of β-catenin in exosomes (Chairoungdua et al.,
2010). In melanocytes the sorting of the luminal domain of
pigment cell-specific protein 17 also depends on the expression
of CD63 to be included into ILV during melanosome formation
(van Niel et al., 2011).
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Lipid-Mediated Sorting
The ability of lipids to laterally segregate and self-organize
into specific membrane subdomains allows sorting platforms
to be organized on cell membranes, including the limiting
membrane of MVE (Bissig and Gruenberg, 2013). Accordingly,
a subset of lipids and lipid-metabolizing enzymes has been
implicated in the sorting of cargo into ILV as well as in
exosome release. Cholesterol is a sterol lipid that plays a key
role in organizing the biophysical properties of cell membranes
(Maxfield and van Meer, 2010). Cholesterol was shown to
be necessary for the formation of highly curved membrane
structures such as caveolae (Chang et al., 1992) and synaptic
vesicles (Thiele et al., 2000). Since cholesterol is highly enriched
in ILV of MVE but poorly represented in lysosomes, a role
for cholesterol was proposed in the intraluminal sorting of
membranes destined for secretion as exosomes (Möbius et al.,
2003). Lysobisphosphatidic acid (LBPA) is a coned-shaped lipid
that is also abundant in internal membranes of MVE (Kobayashi
et al., 1998). LBPA controls the formation of ILV both in
vitro and in vivo through the recruitment of Alix (Matsuo
et al., 2004). However, since LBPA mostly concentrates in
lysosomes and is present in only small amounts in exosomes,
it was proposed that LBPA is not involved in the formation
of ILV with a secretory destination but rather in backfusion of
ILV with the MVE limiting membrane (Bissig and Gruenberg,
2014). Ceramide, another coned-shaped lipid, promotes the
coalescence of membrane domains and induces the spontaneous
curvature of membranes (Castro et al., 2014). The activity of
neutral sphingomyelinase (nSMNase) II, which is the enzyme
that catalyzes the synthesis of ceramide from sphingomyelin, is
required for the inward budding of proteolipid protein-bearing
ILV as well as for its secretion in exosomes in oligodendroglial
Oli-neu cells, while it is not involved in the luminal sorting
of epidermal growth factor receptor (Trajkovic et al., 2008),
which follows the degradative pathway. Phospholipase D, which
is required for the secretion of exosomes in rat basophilic
leukemia 2H3 cells (Laulagnier et al., 2004), is one more
example of lipid-metabolizing enzyme involved in exosome
biogenesis.
BIOGENESIS OF EXOSOMES BY T CELLS
There is little information regarding the cellular machinery that
controls exosome biogenesis in T cells. In exosomes from human
lymphoblasts, tetraspanins and their associated proteins form a
network of interactions that comprise 45% of the total protein
content (Perez-Hernandez et al., 2013). In mice deficient in
tetraspanin CD81, these exosomes have a reduced content of
CD81-associated proteins, such as B-cell receptor, CD20, ICAM-
1, and HLA isotypes (Perez-Hernandez et al., 2013). These
observations indicate a role for TEM in sorting of specific
proteins to ILV destined for exosome secretion. The association
of the oncogene latent membrane protein 1 of Epstein Barr virus
with tetraspanin CD63-enriched microdomains is required for
its sorting into ILV and its secretion via B cell exosomes, as
demonstrated by CD63 silencing (Verweij et al., 2011). Although
the evidence is still preliminary, the role of tetraspanins in protein
sorting to ILV and their ubiquitous presence in exosomes make
it plausible that tetraspanins, and subsequently TEM, also play a
role in exosome biogenesis in T cells. As occurs in Oli-neu cells
(Trajkovic et al., 2008), ceramide is important for the formation
of ILV destined for exosomes in T cells, as silencing of nSMNase
II or inhibition of its enzymatic activity induce a decrease in the
release of exosomes (Mittelbrunn et al., 2011; Ventimiglia et al.,
2015). Some lipid-metabolizing enzymes, such as diacylglycerol
kinase α, accumulate on the limiting membrane of T cell MVE
and control the maturation of MVE and the release of CD63-
containing exosomes in T and B cells (Alonso et al., 2011),
reinforcing the proposed role of lipids in exosome formation by T
cells. A role for condensed membranes in exosome formation by
T cells is further supported by the observation that T cell-derived-
exosomes are enriched in sphingomyelin and cholesterol, as
observed in a recent lipidomic analysis (Bosque et al., 2016).
The observations that neither Hrs nor tsg101 are required for
exosome release by T cells (Mittelbrunn et al., 2011; Ventimiglia
et al., 2015) indicate that, although other ESCRT components
have not been tested yet, exosome biogenesis appears to be
independent of ESCRT machinery unlike in other cell types
(Géminard et al., 2004; Baietti et al., 2012; Colombo et al.,
2013).
MAL is a 17-kDa tetraspanning membrane protein whose
expression is restricted to T cells, specific polarized epithelia
and myelin-forming cells (Alonso and Weissman, 1987). A
characteristic biochemical feature of MAL is its exclusive
association with detergent-insoluble membrane fractions
enriched in condensed membranes (Millán and Alonso, 1998).
MAL is essential for the transport of the tyrosine kinase Lck to
the plasma membrane of T cells, and controls the condensation
of membranes at the immunological synapse, ensuring the
correct sorting of Lck and LAT into this structure (Antón et al.,
2008, 2011). The membrane trafficking processes characterized
so far are dependent on protein machinery. Lipids collaborate
in these processes by helping to bend membranes to form
transport vesicles (e.g., ceramide, LBPA) or by providing sites for
recruiting specific protein machinery (e.g., phosphoinositides).
An important clue about the cellular machinery involved in
sorting of cargo and the biogenesis of exosomes in T cells, as
well as about the mechanisms that regulate the collaboration
between TEM and condensed membranes comes from the study
of the role of the protein MAL during MVE maturation and
the secretion of exosomes in T cells (Ventimiglia et al., 2015).
MAL distributes in tubular-vesicular structures characteristic
of early endosomes, some of which present MVE morphology.
The silencing of MAL in T cells reduces the number of exosomes
secreted, and subsequently the release of the exosome cargo.
This effect was correlated with reduced sorting of CD63 into
the intraluminal space of MVE and its accumulation on the
limiting membrane of aberrant MVE that no longer fuse with
the plasma membrane but, instead, merge with autophagic
vacuoles and lysosomes. Therefore, the protein MAL appears
as a key component of the machinery responsible for exosome
biogenesis and sorting of cargo, including tetraspanins, destined
for exosome delivery in T cells. The role of MAL in Lck
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trafficking, organization of the immunological synapse and
exosome biogenesis is probably related to the capacity of MAL
to organize condensed membrane domains (Antón et al., 2008,
2011; Magal et al., 2009).
From a biochemical point of view exosomes could be
considered to be specialized membranes highly enriched in
TEM and condensed domains. Although these two distinctive
membrane domains are biochemically and functionally
distinguishable entities (Le Naour et al., 2006), it has been
demonstrated that the progression of many cellular processes
rely on the ability of TEM and condensed membranes to
cooperate in order to build functional membrane scaffolds.
There are a number of examples that illustrate a relationship
between condensed membranes and TEM that are consistent
with a possible joint role of these two types of membrane in
exosome biogenesis. For example, the incorporation of the B-cell
receptor into condensed membranes, a key step to ensure the
sustainment and the amplification of B-cell receptor-mediated
signaling, depends on the expression of CD81 (Cherukuri
et al., 2004); in T cells the tetraspanin CD82 mediates the
association of the actin cytoskeleton with compact membranes,
which is necessary for triggering T-cell receptor-dependent
signaling (Delaguillaumie et al., 2004); the incorporation of
CD9 into condensed membranes domains is crucial for the
cell fusion during osteoclastogenesis (Ishii et al., 2006); and
the recruitment of CD63 to filopodia tips during the adhesion
of platelets depends on the membrane compaction (Heijnen
et al., 2003). In this regard, the cooperation between TEM and
condensed membranes could have a key importance during
the biogenesis of exosomes, firstly mediating the organization
of differentiated domains on the limiting membrane of MVE
through the recruitment of specific exosome components,
and then, promoting the invagination of these domains to
form ILV. Supporting a collaboration between condensed
membranes and TEM, it was reported that β-catenin secretion
in exosomes of bone marrow-derived dendritic cells is impaired
FIGURE 2 | Model of MAL function in exosome biogenesis by T cells. (A) The transmembrane protein MAL facilitates the incorporation of TEM into
ceramide-enriched condensed nanodomains at the limiting membrane of MVE. The intraluminal budding of the TEM-condensed mixed nanodomains gives rise to the
ILV that are released as exosomes. Although MAL also intervenes in other membrane trafficking processes, only those related to exosome biogenesis are represented.
(B) In MAL-silenced T cells, TEM are not incorporated efficiently into ILV and accumulate on the limiting membrane of MVE. These aberrant MVE are not able to fuse
with the plasma membrane and divert to lysosomes for degradation.
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in CD9 knockout mice and also by nSMNase II inhibition
(Chairoungdua et al., 2010). Despite these advances, the
mechanisms that regulate the interaction between TEM and
condensed membranes require further investigations. Given the
capacity of MAL to organize condensed membrane domains
(Antón et al., 2008, 2011; Magal et al., 2009), the presence of
ceramide in this type of membrane and the dependence of
the exosome secretion of CD63 on both ceramide and MAL
expression, it is plausible that the correct intraluminal sorting
of CD63 to secretory MVE requires MAL-organized ceramide
patches at the MVE limiting membrane to promote cargo
selection and the inward invagination of the patches leading to
the formation of ILV for exosome secretion (Figure 2).
FUNCTION OF T CELL-DERIVED
EXOSOMES
Although a large number of proteins are commonly found in
exosomes regardless of their cellular origin (Choi et al., 2015), the
protein composition of exosomes varies with cell type, somehow
reflecting the specific functions of the producer cell. For instance,
exosomes derived from B cells carry B-cell receptor subunits
(Rialland et al., 2006) and those released by natural killer cells
contain the cytolitic protein perforin and CD56 (Lugini et al.,
2012), which is a marker of this type of cell. Consistent with
this correlation, normal T cells secrete exosomes containing T-
cell receptor subunits, Src-like tyrosine kinases and adhesion
molecules (Blanchard et al., 2002).
With regard to the function of exosomes secreted by T
cells, diacylglycerol kinase α inhibition is known to increase
the secretion of lethal exosomes bearing membrane-associated
Fas ligand to mediate activation-induced cell death in other
T cells (Alonso et al., 2005). The exosomes derived from
stimulated human CD3+ T cells cooperate with IL2 in promoting
proliferation of autologous resting cells (Wahlgren et al., 2012).
T-cell tolerance of allergic cutaneous contact sensitivity induced
in mice is shown due to exosomes secreted by CD8+ suppressor
T cells (Bryniarski et al., 2013). Also, in mice, Fas ligand-
containing exosomes secreted by activated T cells promote
tumor invasion in lungs by increasing the expression of
matrix metalloproteinase 9 (Cai et al., 2012), and CD8+CD45+
regulatory T cell-released exosomes inhibit CD8+ cytotoxic T-
lymphocyte response and antitumor activity (Zhang et al., 2011).
The exosomes secreted by CD4+ CD25+ regulatory T cells
prolong the survival time of kidney transplants and inhibit T cell
proliferation in rat models, indicating that exosomes contribute
to transplantation tolerance (Yu et al., 2013).
Similar to the case of exosomes from other sources (Valadi
et al., 2007; Kosaka et al., 2010), exosomes secreted by human
T cells deliver biologically active miRNA (Mittelbrunn et al.,
2011). miRNA can be unidirectionally transferred from T cells
to antigen-presenting cells through the immunological synapse
using exosomes as vehicles (Mittelbrunn et al., 2011). The
importance of exosome miRNA in modulating the immune
response is revealed by the observation that Let-7d miRNA,
which is found in exosomes derived from Foxp3+ T regulatory
cells, suppresses T helper 1 cells proliferation and γ-IFN secretion
(Okoye et al., 2014).
In addition to their role in controlling the immune response,
exosomes play a role in pathogenesis, with some pathogens being
able to modulate the secretion of exosomes in the host to favor
its own propagation. For example, the expression of the HIV-1
protein Nef induces the secretion of exosomes either in HIV-
1 infected or in Nef-transfected T cells (Campbell et al., 2008;
Muratori et al., 2009; Lenassi et al., 2010; Raymond et al., 2011;
Shelton et al., 2012; Lee et al., 2013). It has been shown that
HIV-1 usurps the exosome-based intercellular communication
network of T cells to render quiescent T cells permissive to HIV-1
replication (Arenaccio et al., 2014a,b) promoting their apoptosis
(Lenassi et al., 2010) and stimulating an extensive secretory
activity leading to the massive release of microvesicles (Muratori
et al., 2009).
CONCLUSIONS
Exosomes secreted by T cells have emerged as key mediators
of the immune response, modulating the activity of immune
cells. Modulation of the exosome route in T cells, therefore, may
be of therapeutic value for preventing T cell-mediated diseases
such as inflammation or transplant rejection or for interfering
with the progression of HIV-1 infection (Agarwal et al., 2014;
Zhang et al., 2014; De Toro et al., 2015; Liu et al., 2015; Sáenz-
Cuesta et al., 2015). Ceramide, tetraspanins and MAL, which
have been revealed to be important in exosome biogenesis by T
cells, are candidate molecular targets for artificially modulating
exosome production by T cells. A better understanding of the
basicmolecularmechanisms that regulate the release of exosomes
in these cells becomes fundamental not only to gain more insight
into the roles of these vesicles during the onset and progression
of a robust immune response, but also to enable the design of
engineered exosomes for use as therapeutic agents.
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